L39M (p.Leu39Met) variant of ACE2 (Angiotensin-converting enzyme 2)
L39M (p.Leu39Met) in ACE2 (Angiotensin-converting enzyme 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes experimental measurements and structural context.
L39M (p.Leu39Met) variant details
- p.Leu39Met
- NCI-TCGA Cosmic COSV5302
- cosmic curated COSV53024
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available
- ACE2 binding to SARS-CoV-2 spike protein, low affinity: score -0.876